14 Oct 2014

Indian pharma industry not as attractive for acquisitions, says Ajay Piramal


He was one of the original ‘takeover tycoons’ in India’s post-liberalisation era with an appetite for taking over pharmaceutical businesses. Ajay Piramal, Chairman of the Piramal Group, has since diversified his business interests, having sold his then flagship, Piramal Healthcare to Abbott for a whopping $3.7 billion in 2010. 

view the full article here

No comments:

Post a Comment